Marta Massanella

4.7k total citations
79 papers, 2.4k citations indexed

About

Marta Massanella is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Marta Massanella has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Virology, 46 papers in Infectious Diseases and 28 papers in Immunology. Recurrent topics in Marta Massanella's work include HIV Research and Treatment (62 papers), Immune Cell Function and Interaction (26 papers) and HIV/AIDS drug development and treatment (26 papers). Marta Massanella is often cited by papers focused on HIV Research and Treatment (62 papers), Immune Cell Function and Interaction (26 papers) and HIV/AIDS drug development and treatment (26 papers). Marta Massanella collaborates with scholars based in Spain, United States and Canada. Marta Massanella's co-authors include Julià Blanco, Bonaventura Clotet, Nicolas Chomont, Douglas D. Richman, Rémi Fromentin, Eugènia Negredo, Sara Gianella, Jordi Puig, Davey M. Smith and Javier Martínez‐Picado and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Marta Massanella

77 papers receiving 2.4k citations

Peers

Countries citing papers authored by Marta Massanella

Since Specialization

Citations

This map shows the geographic impact of Marta Massanella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Massanella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Massanella more than expected).

Fields of papers citing papers by Marta Massanella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Massanella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Massanella. The network helps show where Marta Massanella may publish in the future.

Co-authorship network of co-authors of Marta Massanella

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Massanella. A scholar is included among the top collaborators of Marta Massanella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Massanella. Marta Massanella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population 2024 ·International Journal of Molecular Sciences ·Cora Loste, (unknown), (unknown), Víctor Urrea, Ana Raquel Ortega Martínez, Sandra González, Jordi Puig, (unknown), Anna Bonjoch, Patricia Echeverría, Marta Massanella, Eugènia Negredo	1
2	Altered Plasma microRNA Signature in Hospitalized COVID-19 Patients Requiring Oxygen Support 2024 ·Microorganisms ·Sandra Franco, Lourdes Mateu, Raquel Pluvinet, (unknown), (unknown), Lauro Sumoy, Marta Massanella, Miguel Ángel Martı́nez	4
3	Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes 2023 ·Nature Communications ·Caroline Dufour, Corentin Richard, Marion Pardons, Marta Massanella, (unknown), Ben Murrell, Bertrand Routy, Réjean Thomas, Jean‐Pierre Routy, Rémi Fromentin, Nicolas Chomont	23
4	Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration 2023 ·SHILAP Revista de lepidopterología ·F. J. Belda, (unknown), (unknown), (unknown), Ana Vivanco, Sílvia Marfil, Edwards Pradenas, Marta Massanella, Julià Blanco, (unknown), Michael J. Crowley	1
5	Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders 2022 ·Pathogens ·(unknown), Cristina Miranda, Sandra González, Irma Casas, Père-Joan Cardona, (unknown), Nieves Sopena, Esteban Reynaga, Marta Massanella, Bonaventura Clotet, Jorge Carrillo, Lourdes Mateu, María Luisa Pedro-Botet	1
6	Neurocognitive Profile of the Post-COVID Condition in Adults in Catalonia—A Mixed Method Prospective Cohort and Nested Case–Control Study: Study Protocol 2022 ·Vaccines ·Rosalía Dacosta‐Aguayo, (unknown), (unknown), Lucía A. Carrasco‐Ribelles, (unknown), (unknown), Rosa García‐Sierra, (unknown), (unknown), Marta Massanella, Josep Puig, José A. Muñoz-Moreno, Lourdes Mateu, Anna Prats, (unknown), María Mataró, Júlia G. Prado, Eva Martínez‐Cáceres, Concepción Violán, Pere Torán‐Monserrat	1
7	Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection 2022 ·International Journal of Molecular Sciences ·Ifeanyi Jude Ezeonwumelu, Edurne García-Vidal, Eva Riveira‐Muñoz, Eudald Felip, (unknown), (unknown), Marta Massanella, Guillem Sirera, Bonaventura Clotet, Ester Ballana, Roger Badía	1
8	Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors 2022 ·Frontiers in Immunology ·Athina Kilpeläinen, (unknown), (unknown), Dan Ouchi, Ruth Peña, Bibiana Quirant‐Sánchez, (unknown), Anna Chamorro, Ignacio Blanco, Eva Martínez‐Cáceres, Roger Paredes, Lourdes Mateu, Jorge Carrillo, Julià Blanco, Christian Brander, Marta Massanella, Bonaventura Clotet, Júlia G. Prado	1
9	SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients 2021 ·Viruses ·(unknown), Eva Riveira‐Muñoz, Clara Barrios, Vanesa Palau, María Nevot, (unknown), Jordi Senserrich, Marta Massanella, Bonaventura Clotet, Cecilia Cabrera, (unknown), Marta Crespo, Julio Pascual, Marta Riera, Ester Ballana	15
10	Stable neutralizing-antibody levels 6 months after mild and severe COVID-19 episode 2021 ·Edwards Pradenas, Benjamin Trinité, Víctor Urrea, Sílvia Marfil, Carlos Ávila‐Nieto, Maria Luisa Rodrı́guez de la Concepción, Ferran Tarrés-Freixas, Nuria Izquierdo‐Useros, Rodolfo Paredes, Lourdes Mateu, Anna Chamorro, Marta Massanella, Jorge F. Carrillo, Bonaventura Clotet, (unknown)	0
11	TL1A–DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1–Specific T Cell Responses 2020 ·The Journal of Immunology ·(unknown), Àlex Olvera, (unknown), Anuska Llano, Beatriz Mothe, Marta Massanella, Judith Dalmau, Carmela Ganoza, Jorge Sánchez, M. Luz Calle, Bonaventura Clotet, Javier Martínez‐Picado, Eugènia Negredo, Julià Blanco, Dennis J. Hartigan-O’Connor, Christian Brander, Marta Ruiz‐Riol	3
12	Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection 2019 ·PLoS Pathogens ·Marion Pardons, Amy E. Baxter, Marta Massanella, Amélie Pagliuzza, Rémi Fromentin, Caroline Dufour, Louise Leyre, Jean‐Pierre Routy, Daniel E. Kaufmann, Nicolas Chomont	151
13	Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy 2019 ·Journal of Virology ·Aaron Christensen-Quick, Marta Massanella, (unknown), Stephen A. Rawlings, Celsa A. Spina, (unknown), Rachel Schrier, Masato Nakazawa, Christy M. Anderson, Sara Gianella	29
14	Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy 2019 ·Journal of Virology ·Marta Massanella, Wendy Bakeman, Pasiri Sithinamsuwan, James L. K. Fletcher, Nitiya Chomchey, Somporn Tipsuk, Thep Chalermchai, Jean‐Pierre Routy, Jintanat Ananworanich, Victor Valcour, Nicolas Chomont	22
15	Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size 2019 ·PLoS Computational Biology ·Daniel I. S. Rosenbloom, Peter Bacchetti, Mars Stone, Xutao Deng, Ronald J. Bosch, Douglas D. Richman, Janet D. Siliciano, John W. Mellors, Steven G. Deeks, Roger G. Ptak, Rebecca Hoh, Sheila M. Keating, (unknown), Marta Massanella, Jun Lai, Michele D. Sobolewski, Deanna A. Kulpa, Michael P. Busch, (unknown)	17
16	Improved assays to measure and characterize the inducible HIV reservoir 2018 ·EBioMedicine ·Marta Massanella, Christina Yek, Steven M. Lada, Masato Nakazawa, (unknown), (unknown), Douglas D. Richman	38
17	Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise 2018 ·Retrovirology ·(unknown), Marta Massanella, Nicolas Chomont	23
18	Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique 2017 ·Nature Protocols ·Amy E. Baxter, Julia Niessl, Rémi Fromentin, Jonathan Richard, Filippos Porichis, Marta Massanella, Nathalie Brassard, Nirmin Alsahafi, Jean‐Pierre Routy, Andrés Finzi, Nicolas Chomont, Daniel E. Kaufmann	43
19	Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery 2017 ·Scientific Reports ·(unknown), Elisabet García, Víctor Urrea, Marta Massanella, Jordi Puig, Eugènia Negredo, Bonaventura Clotet, Julià Blanco, Cecilia Cabrera	12
20	Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection 2016 ·Journal of Virology ·Sara Gianella, Christy M. Anderson, Susanna R. Var, Michelli F. Oliveira, Steven M. Lada, Milenka V. Vargas, Marta Massanella, Susan J. Little, Douglas D. Richman, Matthew C. Strain, Josué Pérez‐Santiago, Davey M. Smith	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact